Упрощенная HTML-версия
139
ment of bleeding associated with renal failure // N. Engl. J. - 1986. - N 315. - 12. -
P. 731-735.
229.Lopez, L.M. et al. Scin patch and vaginal ring versus combined oral contraceptives
for contraception (Review) // Cochrane Database Syst. Rev. - 2010. - N 3. - P. 335-
358.
230. Mannucci, P.М., Bettega, D., Chantarancvul, V. е. а. Effect of tamoxifen on meas-
urements of hemostasis in healthy women // Arch. Intern. Med. - 1996. - N 156. -
16. - P. 11806-18110.
231. Marttunen, М.В., Pyrhunen, S., Tiitinen, А.Е. е. а. Effect of antiestrogen regimen
on prostacyclin and thromboxane-A in postmenopause patients with breast cancer:
evidence of significance hypertension, smoking or previos use of estrogen therapy
// Prostaglzndins. - 1996. - N 52. - 4. - P. 317- 326.
232.Miller, С.P., Jurkovsky, е. а. In vitro antioxidant effects of estrogens with а hin-
dered 3-oh function on the copper-induced oxidation of LDL // Steroids. - 1996. -
N 61. - 5. - P. 305-308.
233. Mitchell, Н.С. Effect of estrogens and а progestogen on platelet adhesiveness and
aggregation in rabbits // J. Lab. Clin. Med. - 1974. - Р. 79-89.
234. Mishell, DRJ // New Engl. J. Med. - 1995. - 11989. - 320. - P. 777-787.
235. Mueck, А.О., Seeger, Н., Lippert, Т.Н. Estradiol inhibits LDL oxidation: to the
progestins medroxyprogesterone acetate and norethhisterone acetate influence this
effect? // Сlin. Ехр. Obstetr. Gynecol. - 1998. - N 25. - 1. - P. 26-28.
236. Nagasava, Н., Kim, В.К., Steine,r В., Baldin,i М.G. Inhibition of thrombin-
neutralising activity of antithrombin III by steroid hormones // Thromb. Haemost. -
1982. - N 47. - 2. - P. 157-161.
237. Nakano, Y., Oshim,a Т., Matsuura, е. а. Effect of 17-pestradiol on inhibition of
platelet aggregation in vitro // Arterioscl. Thromb. Vase. Biol. - 1998. - N 18. - 6. -
P. 961-967.
238. Nasr, А., Breckwoldt, В. Estrogen replacement therapy and cardiovascular protec-
tion: lipid mechanism are the tip of an iceberg // Gynecol. Endocrinol. - 1998. - N
12. - 1. - P. 43-59.